Iron Mobilisation and Cellular Protection by a New Synthetic Chelator O-Trensox
- 24 June 1998
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (11) , 1797-1806
- https://doi.org/10.1016/s0006-2952(98)00009-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Inhibition of iron toxicity in human hepatocyte cultures by pyoverdins Pa A and Pf, the peptidic siderophores of Pseudomonas aeruginosa and fluorescensLiver International, 2008
- Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94Journal of Hepatology, 1995
- Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia MajorNew England Journal of Medicine, 1995
- Inhibition of iron toxicity in rat hepatocyte cultures by pyoverdin Pa A, the peptidic fluorescent siderophore of Pseudomonas aeruginosaToxicology in Vitro, 1993
- Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trialBritish Journal of Haematology, 1992
- Studies of in vivo iron mobilization by chelators in the ferrocene-loaded ratBiochemical Pharmacology, 1992
- Inhibition of iron overload toxicity in rat hepatocyte cultures by pyoverdin Pf, the siderophore of pseudomonas fluorescensBiochemical Pharmacology, 1992
- Desferrithiocin and desferrioxamine BBiochemical Pharmacology, 1989
- An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelatorsBiochemical Pharmacology, 1986
- ABSORPTION AND EXCRETION OF IRONThe Lancet, 1937